Type 2 Diabetes Clinical Trials in Morehead City, North Carolina

5 studies are recruiting for type 2 diabetes in Morehead City, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

   This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes and with a body mass index (BMI) of 23 kg/m2 or higher can join. The study has 3 parts. In each part the study compares survodutide with placebo. Surv…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Centricity Research - Morehead City, Morehead City, North Carolina

   Locations

   121 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07754461 on ClinicalTrials.gov

2. A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

   The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a stable dose of semaglutide or tirzepatide. Participation in the study will last about 9 months.

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Lucas Research, Inc., Morehead City, North Carolina

   Locations

   60 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT06897475 on ClinicalTrials.gov

3. Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

   CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in th…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Lucas Research Inc, Morehead City, North Carolina

   Locations

   61 in total

   Run by

   Sparrow Pharmaceuticals

   See if you can join NCT07296484 on ClinicalTrials.gov

4. AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

   This study is being conducted to find out how well zenagamtide works and how safe it is compared to insulin glargine in participants with type 2 diabetes who are at higher risk of heart and blood vessel problems and are already taking 1 to 3 diabetes medications. There are 2 study treatments in thi…

   Stage

   Phase 3

   Ages

   45 and older

   Site

   Carteret Medical Group, Morehead City, North Carolina

   Locations

   330 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07797335 on ClinicalTrials.gov

5. A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

   This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive eit…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Carteret Medical Group, Morehead City, North Carolina

   Locations

   303 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07564414 on ClinicalTrials.gov